Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

ACADIA Pharmaceuticals Inc (NASDAQ:ACAD)

31.43
Delayed Data
As of Jun 24
 -2.07 / -6.18%
Today’s Change
16.64
Today|||52-Week Range
51.99
-11.84%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2012

2013

2014

2015
Revenue and IncomeNet Revenues4.9M1.1M120.0K61.0K
 
 
 
 
 
Depreciation And Amortization109.0K79.0K206.0K647.0K
 
 
 
 
 
 
Operating ExpensesGross Income----------
General Expenses25.7M39.4M93.1M161.5M
 
 
 
 
 
Other Operating Expenses0.000.000.002.5M
 
 
Research And Development18.8M26.7M60.6M73.9M
 
 
 
 
 
Total Operating Expenses25.8M39.4M93.4M164.7M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-20.9M-38.3M-93.2M-164.6M
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-20.8M-37.9M-92.5M-164.1M
 
 
 
 
 
Income Taxes0.000.000.00-330.0K
 
 
Net Income-20.8M-37.9M-92.5M-164.4M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS55.1M85.7M97.2M100.6M
 
 
 
 
 
Shares To Calculate EPS Diluted55.1M85.7M97.2M100.6M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.38-$0.44-$0.95-$1.63
 
 
 
 
 
EPS Diluted-$0.38-$0.44-$0.95-$1.63